Clinical Trials Directory

Trials / Completed

CompletedNCT04074291

Cross Cultural Validation of the Italian Version of the Bt-DUX

Cross Cultural Validation of the Italian Version of the Bt-DUX: A Subjective Measure of Health Related Quality of Life in Patients Who Underwent Surgery for Lower Extremity Malignant Bone Tumour

Status
Completed
Phase
Study type
Observational
Enrollment
51 (actual)
Sponsor
Istituto Ortopedico Rizzoli · Academic / Other
Sex
All
Age
15 Years – 25 Years
Healthy volunteers

Summary

The purpose of the presented study is to translate the English Bt-DUX (Bt-DUX-Eng) questionnaire into the Italian language and then examine the validity of the Italian version of the Bt-DUX (Bt-DUX-It).

Detailed description

Validation of the Italian Bt-DUX: Cross sectional study among patients of the Istituto Ortopedico Rizzoli, Bologna, Italy, will carry out. All patients who underwent a surgical intervention due to a malignant bone tumour in the leg will be identified through hospital records and a survey consisting of different QoL questionnaires will be executed: Bt-DUX, EORTC QLQ C-30, The Toronto Extremity Salvage Score (TESS).

Conditions

Timeline

Start date
2019-08-20
Primary completion
2020-01-30
Completion
2020-01-30
First posted
2019-08-30
Last updated
2021-05-12

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT04074291. Inclusion in this directory is not an endorsement.